retatrutide gip glp-1 glucagon receptor agonist Retatrutide vs. Tirzepatide: The Next-Gen

As body weight reduces, pressure on the airway may decrease, supporting better sleep quality over time

Patients have questions about dosage, side effects, and how GLP-1s interact with their daily lives

Who must avoid it entirely in the class framing: anyone pregnant or breastfeeding, anyone with the personal/family MTC or MEN 2 history above, and anyone with prior serious hypersensitivity to a GLP-1 agonist

It is hard to understand why insurance company decisions would be better or more evidence-based than those of the board-certified physicians who are prescribing the medications, and who know and have examined the patient

Updated April 1, 2025

Common medication triggers include antidepressants (particularly SSRIs and SNRIs), antihistamines, dopamine antagonists, and some antipsychotics